β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(sα) mouse

Journal of Clinical Investigation

Volumn 104, Issue 5, 1999, Pages 551-558

  Asai, Kuniya ^a   Yang, Gui Ping ^a   Geng, Yong Jian ^a   Takagi, Gen ^a   Bishop, Sanford ^a   Ishikawa, Yoshihiro ^a   Shannon, Richard P ^b   Wagner, Thomas E ^c   Vatner, Dorothy E ^a   Homcy, Charles J ^d   Vatner, Stephen F ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c CLEMSON UNIVERSITY   (United States)

^d MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE OVEREXPRESSION; HEART DILATATION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HISTOLOGY; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032699668     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7418     Document Type: Article

References (41)

1. Hittinger, L., et al. 1995. Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation. 92:978-986.
2. Koch, W.J., et al. 1995. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 268:1350-1353.
3. 2-adrenergic receptor. Science. 264:582-586.
4. Rohrer, D.K., et al. 1996. Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl. Acad. Sci. USA. 93:7375-7380.
5. Wakasaki, H., et al. 1997. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc. Natl. Acad. Sci. USA. 94:9320-9325.
6. 1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc. Natl. Acad. Sci. USA. 94:6391-6396.
7. Conner, D.A., et al. 1997. β-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to β-adrenergic stimulation. Circ. Res. 81:1021-1026.
8. sα protein in the hearts of transgenic mice. J. Clin. Invest. 95:1676-1683.
9. sα overexpression. Circ. Res. 78:517-524.
10. sα. Circ. Res. 82:416-423.
11. 2+ channel pathways. J. Clin. Invest. 103:1089-1097.
12. Vatner, D.E., et al. 1998. Overexpression of myocardial Gsα prevents full expression of catecholamine desensitization despite increased β-adrenergic receptor kinase. J. Clin. Invest. 101:1916-1922.
13. Geng, Y.J., et al. 1999. Apoptosis of cardiac myocytes in Gsα transgenic mice. Circ. Res. 84:34-42.
14. sα overexpression. Am. J. Physiol. 272:H585-H589.
15. National Institutes of Health, Office of Science and Health Reports. 1996. Guide for care and use of laboratory animals. Publication no. 83-23. Office of Science and Health Reports, Department of Health and Human Services. Bethesda, MD.
16. Fentzke, R.C., Korcarz, C.E.; Lang, R.M., Lin, H., and Leiden, J.M. 1998. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J. Clin. Invest. 101:2415-2426.
17. Arber, S., et al. 1997. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell. 88:393-403.
18. Sato, Y., et al. 1998. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J. Biol. Chem. 273:28470-28477.
19. Kubota, T., et al. 1997. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ. Res. 81:627-635.
20. Franco, F., et al. 1999. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation. 99:448-454.
21. Edwards, J.G., et al. 1996. Cardiomyopathy in transgenic myf5 mice. Circ. Res. 78:379-387.
22. Sussman, M.A., et al. 1998. Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice. J. Clin. Invest. 101:51-61.
23. Colbert, M.C., et al. 1997. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J. Clin. Invest. 100:1958-1968.
24. Engelhardt, S., Hein, L., Wiesmann, F., and Lohse, M.J. 1999. Progressive hypertrophy and heart failure in β-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. USA. 96:7059-7064.
25. Ieki, K., et al. 1989. Effect of long-term treatment with β-blocker on cardiac hypertrophy in SHR. J. Mol. Cell. Cardiol. 21(Suppl. 5):113-119.
26. Barone, F.C., Campbell, W.G., Jr., Nelson, A.H., and Feuerstein, G.Z. 1998. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling. J. Hypertens. 16:871-884.
27. Rosenbaum, J.S., Ginsburg, R., Billingham, M.E., and Hoffman, B.B. 1987. Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma. J. Pharmacol. Exp. Ther. 241:354-360.
28. 2 agonist and a β-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion. J. Cardiovasc. Pharmacol. 31:601-608.
29. Narula, J., et al. 1996. Apoptosis in myocytes in end-stage heart failure. N. Engl. J. Med. 335:1182-1189.
30. Olivetti, G., et al. 1997. Apoptosis in the failing human heart. N. Engl. J. Med. 336:1131-1141.
31. Liu, Y., et al. 1995. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab. Invest. 73:771-787.
32. Teiger, E., et al. 1996. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J. Clin. Invest. 97:2891-2897.
33. Cheng, W., et al. 1995. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96:2247-2259.
34. Shizukuda, Y., et al. 1998. β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am. J. Physiol. 275:H961-H968.
35. Communal, C., Singh, K., Pimentel, D.R., and Colucci, W.S. 1998. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation. 98:1329-1334.
36. Anversa, P. 1998. Myocyte apoptosis and heart failure. Eur. Heart J. 19:359-360.
37. Yeh, E.T. 1997. Life and death in the cardiovascular system. Circulation. 95:782-786.
38. CIBIS Investigators and Committees. 1994. A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 90:1765-1773.
39. Lechat, P., et al. 1998. Clinical effects of β-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 98:1184-1191.
40. Packer, M., et al. 1996. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 334:1349-1355.
41. CIBIS Investigators and Committees. 1999. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 353:9-13.